P. Miao

Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinoma.

D. Gao, Jian Zhou, Yinghong Shi, 2017, Oncotarget.

Abstract 1750: Analysis of non-metastatic HCC patient tumors revealed the significance of cell cycle regulation and tumor immunity in association with overall survival and identified clinically relevant druggable targets

G. Hampton, L. Amler, Bonnie Liu, 2017 .

Tumor immune cell infiltration score based model predicts prognosis in multiple myeloma

Zhenzhen Chen, Yaping Xie, Ying Xu, 2022, Scientific Reports.

Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinoma

D. Gao, Jian Zhou, Yinghong Shi, 2017, Oncotarget.